HC Wainwright Reaffirms Buy Rating for Vigil Neuroscience (NASDAQ:VIGL)

HC Wainwright restated their buy rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a report issued on Thursday morning, Benzinga reports. They currently have a $17.00 price objective on the stock. A number of other analysts also recently weighed in on the stock. JMP Securities restated a market outperform rating and issued […]

Leave a Reply

Your email address will not be published.

Previous post Financial Contrast: Sanofi (NASDAQ:SNY) vs. Parnell Pharmaceuticals (OTCMKTS:PARNF)
Next post Trisura Group (TSE:TSU) Price Target Raised to C$62.00